G. Nardo

发表

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation

Giulia Guzzo, Vincenzo Ciminale, Andrea Rasola, 2014, Oncotarget.

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients

M. Rugge, V. Barbieri, A. Amadori, 2013, Oncoscience.

Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.

D. Calistri, S. Indraccolo, P. Conte, 2016, Lung cancer.

Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients

S. Indraccolo, V. Tosello, P. Del Bianco, 2021, Diagnostics.

Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.

R. Fiorotto, L. Fabris, M. Cadamuro, 2019, Journal of hepatology.

LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and &ggr;‐irradiation

M. Curtarello, S. Indraccolo, E. Iorio, 2018, Biochemical pharmacology.

Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors

M. Fassan, S. Indraccolo, P. Conte, 2022, British Journal of Cancer.

Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death.

Mario Plebani, Vincenzo Ciminale, Wolfgang Mueller-Klieser, 2008, The American journal of pathology.

Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors

S. Indraccolo, M. Presta, R. Ronca, 2011, Molecular Cancer Therapeutics.

Involvement of NADPH Oxidase 1 in Liver Kinase B1-Mediated Effects on Tumor Angiogenesis and Growth

S. Indraccolo, M. Silic-Benussi, V. Ciminale, 2018, Front. Oncol..

Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome

M. Fassan, R. Rosell, S. Indraccolo, 2021, Translational lung cancer research.

Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma

P. Pontisso, G. Ceolotto, S. Indraccolo, 2021, Biology.

Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors

S. Indraccolo, L. Bonanno, G. Nardo, 2021, Frontiers in Oncology.

RNA interference: implications for cancer treatment.

S. Indraccolo, M. Masiero, G. Nardo, 2007, Molecular aspects of medicine.

Platelet‐derived growth factor‐D and Rho GTPases regulate recruitment of cancer‐associated fibroblasts in cholangiocarcinoma

R. Fiorotto, L. Fabris, M. Cadamuro, 2013, Hepatology.

In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach

G. Esposito, S. Indraccolo, P. Del Bianco, 2020, Frontiers in Oncology.

VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells.

R. Bertorelle, G. Esposito, A. Msaki, 2015, Cancer research.

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab

G. Sozzi, R. Bertorelle, G. Esposito, 2017, Clinical Cancer Research.

Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.

A. Rosato, L. Fabris, M. Cadamuro, 2016, Cancer research.

Nuclear expression of S100A4 calcium‐binding protein increases cholangiocarcinoma invasiveness and metastasization

M. Rugge, J. Dziura, L. Fabris, 2011, Hepatology.

Metabolic effects of anti-angiogenic therapy in tumors.

M. Curtarello, S. Indraccolo, G. Nardo, 2012, Biochimie.

Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.

R. Bertorelle, L. Bonaldi, S. Indraccolo, 2010, Anticancer research.

Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization.

O. Thews, G. Esposito, M. Curtarello, 2011, Cancer research.

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.

A. Del Conte, S. Indraccolo, P. Conte, 2019, Clinical lung cancer.

alk rearranged adenocarcinoma arising in lung lymphangioleiomyomatosis of a patient with tuberous sclerosis complex case report and plausible explanations

F. Calabrese, F. Pezzuto, G. Pasello, 2019 .

Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients

S. Indraccolo, A. Pavan, S. Frega, 2019, International journal of molecular sciences.

Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system

S. Indraccolo, W. Mueller‐Klieser, G. Nardo, 2015, Cellular Oncology.

A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients

A. Del Conte, S. Girlando, S. Indraccolo, 2020, Diagnostics.

Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer

M. Fassan, S. Indraccolo, P. Conte, 2020, British Journal of Cancer.